CVS Health plans $2.5B bond sale to repurchase debt: Bloomberg

CVS Health is preparing to raise up to $2.5 billion through a bond sale, Bloomberg reported Dec. 2. 

Advertisement

The company has engaged Barclays, Citigroup and Goldman Sachs to arrange investor calls, sources told the news outlet. The bonds will have hybrid characteristics, combining elements of debt and equity and are expected to be used to repurchase debt. 

CVS also announced a plan to buy back up to $2 billion of bonds issued by CVS and its Aetna insurance unit, including approximately $950 million in notes due in March, along with longer-term bonds. 

The bond sale and debt repurchase are a part of CVS’ strategy to manage its debt load, which has grown due to acquisitions such as the $70 million purchase of Aetna in 2018, the report said. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.